The FDA has approved the first oral pill version of Wegovy for weight management. The pill contains semaglutide, the same active ingredient found in the injectable form and other GLP-1 agonists. Experts believe this new daily pill formulation will improve patient adherence by eliminating the barrier of needle phobia and normalizing obesity treatment similar to hypertension management.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.